Medical Technology

@xconomy.com 4 years ago

Early Bird Sale Ends Today for Xcelerating Life Sciences Boston: Biopharma’s Future in Digital Health

@xconomy.com 4 years ago

With $45M, Mammoth Bio Expects Big Things From Tiny CRISPR Cas14

@xconomy.com 4 years ago

Schrödinger Sets Course for IPO to Support Growing Internal Pipeline

@xconomy.com 4 years ago

Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More

@xconomy.com 4 years ago

With $35M, Whole Biome Eyes 2020 Launch of Medical Food for Diabetes

@xconomy.com 5 years ago

Pharma CEOs to Senate: We Will Lower Drug Prices if Rebates Go Away

@xconomy.com 5 years ago

ESMO ’18: Precision Meds, Breast, Lung, and More from the Cancer Front

@xconomy.com 5 years ago

With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?

@xconomy.com 5 years ago

CRISPR Risks? Researchers Stoke Fears of Cancer in Gene-Edited Cells

@xconomy.com 5 years ago

Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More

@xconomy.com 5 years ago

Fixing the Clinical Trial Bottleneck by Making Patients a Priority

@xconomy.com 5 years ago

Synthorx Raises $63M to Advance Suite of Enhanced Cytokine Drugs

@venturebeat.com 6 years ago

Menlo Ventures banks on tech-driven life sciences, adds Greg Yap as new partner